Aim-To assess the value and safety of fasts for investigating hypoglycaemia or suspected metabolic disease. Study design-Review of all diagnostic fasts performed over a 2.5 year period. Setting-The neonatal intensive care unit and programmed investigation unit at a tertiary referral centre for endocrinology and metabolic disease. Results-138 diagnostic fasts were performed during the study period. Hypoglycaemia (< 2.6 mmol/l) occurred in 54 cases but in only four did the blood glucose concentration fall below 1.5 mmolIl. One patient became unwell as a result of a fast, but prompt treatment averted any sequelae. Specific endocrine or metabolic defects were identified in 30 cases, the most common being hyperinsulinism andoxidation defects. Conclusions-Fasting is safe if conducted on an experienced unit with appropriate guidelines. It continues to provide useful information for diagnosis and management, particularly in cases of hyperinsulinism. Diagnoses should, however, be established by lower risk procedures whenever possible. Thus specimens for metabolic and endocrine studies should be obtained during the presenting episode and blood acylcarnitine species should be analysed prior to fasting.
Hypoglycaemia is a common paediatric problem. Moreover, recurrent or severe episodes of hypoglycaemia have significant morbidity and mortality, with the risk of sudden death or long term neurological impairment. Specific treatment depends on the cause, ranging from subtotal pancreatectomy in the more severe forms of hyperinsulinism to avoidance of fasting and dietary modification in fat oxidation disorders.
Diagnosis is best achieved by measuring hormone and metabolite concentrations in blood and organic acids in urine during the presenting episode. There have been several publications documenting the normal childhood response to fasting1"5 and the abnormalities found in various conditions."9 Fasting is, however, widely regarded as a high risk procedure. The increasing availability of alternative diagnostic techniques makes it important to assess the safety and value of diagnostic fasts in an unselected series of patients. We have therefore reviewed all the diagnostic fasts performed at a tertiary referral centre over a 2.5 year period.
Methods
This survey included all patients fasted for diagnostic purposes at Great Ormond Street Hospital over a 2.5 year period, between January 1993 and July 1995.
PROTOCOLS FOR DLAGNOSTIC FASTS
Energy withdrawal for diagnostic purposes followed one of two protocols. The first protocol was used for neonates with severe hypoglycaemia, in whom hyperinsulinism was suspected. These patients were almost always on an intensive care unit, receiving intravenous glucose infusions. The diagnosis was established by stopping the infusion and monitoring the blood glucose concentration every 15 minutes until hypoglycaemia (< 2.6 mmol/l) supervened. Blood specimens for metabolite and hormone levels were obtained before correction of the hypoglycaemia; the next urine specimen was sent for organic acid analysis (table 1) .
The second protocol was used for older children. These patients were fasted on a programmed investigation unit, where they were continuously observed by staff experienced in the procedure. The maximum duration of fasting was determined by the age of the child (table 2) and by the history; the fast was terminated before this if the child became hypoglycaemic or symptomatic, or if intravenous access was lost. Blood glucose was monitored hourly from the first missed feed onwards, the frequency being increased if the concentration fell rapidly or if there were clinical concerns. At least three blood samples were obtained during the course of the fast, metabolite and hormone levels being measured as indicated in table 1. Organic acids were analysed by gas In normal subjects, circulating NEFA and ketone body concentrations rise simultaneously during fasting. Reanalysis of published data on normal fasting children (Bartlett et aP and Bonnefont et al7 with permission) suggested that the logarithms of the NEFA and ketone concentrations were linearly related; there was no significant difference between the regression lines for data from the two sources. Figure 1 shows the 95% predictive intervals for the relationship between NEFA and 3-hydroxybutyrate concentrations, based on the combined data. A rise in the NEFA concentration out of proportion to the rise in ketone bodies suggests a defect of ,B-oxidation or ketone synthesis. Measurements of P-oxidation flux'4 were undertaken in such cases and also in other patients whose urinary organic acids or blood acylcarnitine profiles suggested defects of ,B-oxidation. Fructose 1,6-bisphosphatase and enzymes of f-oxidation or glycogen metabolism were assayed when appropriate.
Results

INDICATIONS
During the 2.5 year study period, diagnostic fasts were performed on 138 patients. The age distribution is shown in table 2. Fasts were undertaken in a further nine patients with hyperinsulinism to monitor the response to treatment. As these fasts were not strictly diagnostic, they are not considered further in this article.
Hypoglycaemia was much the commonest indication for the diagnostic fast ( blood glucose level fall below 1.5 mmol/l. Two of these children were subsequently shown to have fructose bisphosphatase deficiency, one had hyperinsulinism and one had 'ketotic hypoglycaemia'. Only one patient became unwell as a result of the procedure. This child, who had fructose 1,6-bisphosphatase deficiency, became acidotic and mildly encephalopathic but made an uneventful recovery with intravenous glucose and bicarbonate; there have been no sequelae. Table 4 shows the final diagnoses in the 138 patients. Specific endocrine or metabolic defects have been identified in 30 cases, the most common being hyperinsulinism and 0-oxidation disorders.
DIAGNOSES
Eleven new cases of hyperinsulinism were diagnosed. Six of these presented as neonates, while three were aged over 1 year. In four cases, hyperinsulinism appeared to be a transient neonatal disorder: they were initially treated with diazoxide but this was later withdrawn without problems and repeat fasts showed no abnormality. Four of the others are still on diazoxide, attempts to withdraw it having led to hypoglycaemia. The remaining three required surgery due to failed medical management. One case of hyperproinsulinaemia was also identified, presenting with neonatal hypoglycaemia, impaired lipolysis, low insulin, and grossly elevated proinsulin levels (O A F Bodamer et al, in preparation)
Ten patients had raised NEFA:ketone ratios at the end of their fasts (fig 1) . In six of these, n-oxidation defects were suggested by the pattern of organic aciduria or acylcarnitines and confirmed by low ,-oxidation flux in fibroblasts. Four children had medium chain acylCoA dehydrogenase (MCAD) deficiency, one had glutaric aciduria type II, and one had carnitine-acylcarnitine translocase deficiency. In three other patients the NEFA:ketone ratio was just above the 95% predictive interval for normal children but the ,B-oxidation flux in cultured fibroblasts was normal and the urine organic acids showed no evidence of a ,-oxidation defect. The remaining child had mild hypoglycaemia (2.3 mmol/l) after 18 hours fasting with a markedly raised plasma NEFA concentration (3.96 mmol/l) relative to the blood 3-hydroxybutyrate concentration (0.02 mmol/l). Ketogenesis was also impaired following a long chain fat load but P-oxidation flux in cultured fibroblasts was normal. The most likely diagnosis appears to be 3-hydroxy-3-methylglutaryl-CoA synthase deficiency."
Lactic acidaemia ( > 2.2 mmol/l) occurred in 10 patients. Both the children in whom the concentration exceeded 4 mmolIl had fructose 1,6-bisphosphatase deficiency, confirmed by assay in leucocytes.'6 Milder lactic acidaemia was found in a child with methylmalonic aciduria associated with vitamin B-12 deficiency and also in the child with carnitineacylcarnitine translocase deficiency. Two children had consistently raised blood lactate concentrations and were subsequently shown to have markedly raised levels in the cerebrospinal fluid; the evolving clinical and neuroradiological picture strongly suggested respiratory chain disease, though muscle histochemistry showed normal cytochrome oxidase activity and biochemical assays of the respiratory chain were not performed. In the remaining four patients, blood lactate concentrations were only transiently raised in single specimens and were attributed to difficulty in obtaining the blood sample.
No cases of glucose 6-phosphatase deficiency were identified in this study. During its course, however, three cases were diagnosed at this hospital without recourse to fasting, on the basis of the clinical and biochemical findings. Two of the patients fasted were subsequently shown to have other glycogenoses (phosphorylase b kinase deficiency in one and as yet undefined in the other). One patient had markedly raised branched chain amino acid concentrations at the end of the fast and a mild variant of maple syrup urine disease was ultimately diagnosed. " We found no correlation between the plasma growth hormone and glucose concentrations at the end of the fasts. In three patients, hypopituitarism was suspected on account of the clinical features (short stature in two and a micropenis in one). Glucagon provocation tests showed growth hormone deficiency in all three. One of these also had secondary adrenocortical insufficiency; a second child with growth hormone deficiency had a low plasma cortisol (264 nmol/l) at the time of fasting hypoglycaemia but a normal cortisol response to glucagon.
Six other patients had plasma cortisol concentrations < 400 nmol/l at the time of fasting hypoglycaemia, three having concentrations of 200 nmol/l or less (blood glucose 1.1 to 2.2 mmol/l). The two patients with the lowest cortisol levels had hyperinsulinism, as did one other patient. None of the six patients appears to have had true adrenocortical insufficiency. Four were subsequently shown to have normal cortisol responses to glucagon and one had a normal response to spontaneous hypoglycaemia. The remaining patient had no further problems following the introduction of diazoxide, and investigations of adrenocortical function have not been pursued.
No diagnosis was established in 32 patients who became hypoglycaemic during the fast. In 16 of these, the hypoglycaemia was mild ( > 2.2 mmol/1) but in eight the blood glucose concentration fell to 1.9 mmol/l or less. In all cases the blood 3-hydroxybutyrate concentration exceeded 1.3 mmolI and in all but four it exceeded 2.2 mmolIl. NEFA:ketone relations were consistently normal (figure) as were the urinary organic acids. These patients have been labelled as having 'ketotic hypoglycaemia'. Sixty patients showed no abnormality during their diagnostic fasts and have been classified as normal. Twenty six of these, however, had documented hypoglycaemia elsewhere, emphasising the importance of obtaining specimens during the presenting episode and illustrating that the distinction between these patients and those with 'ketotic hypoglycaemia'is somewhat arbitrary. 
TECHNIQUES
This survey suggests that diagnostic fasts are safe, if conducted on an experienced unit with careful monitoring. Though 54 patients became hypoglycaemic, the blood glucose concentration only fell below 1.5 mmol/l in four cases. Two of these had fructose 1,6-bisphosphatase deficiency, including the only child who became unwell as a result of his fast. Diagnostic fasts may be particularly hazardous in this condition and, if it is suspected, it may be best to proceed directly to assay of the enzyme in leucocytes, which usually reveals the defect. Acidosis was known to have accompanied hypoglycaemia in the presenting episodes of both of our patients and in retrospect, given that fasting was undertaken, blood pH should have been monitored as well as blood glucose concentration.
The safety of diagnostic fasts in 3-oxidation disorders has also been questioned. Indeed, elsewhere a child with MCAD deficiency died following prolonged fasting for diagnostic pur- poses."8 In this study, none of the patients with ,-oxidation defects suffered any complications.
Outside the study period, however, fasting did provoke mild rhabdomyolysis (without myoglobinuria) in a child with very long chain acyl-CoA dehydrogenase deficiency. For many ,-oxidation disorders, analysis of blood acylcarnitines by tandem mass spectrometry offers a safer method of diagnosis, abnormalities being present even between episodes of metabolic decompensation.'9 It is now our policy always to analyse acylcarnitine species in nonfasting blood spots, before undertaking diagnostic fasts. During the last 18 months of this study, such analysis allowed identification of four cases of MCAD deficiency, one case of long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, one case of very long chain acyl-CoA dehydrogenase deficiency and one case of glutaric aciduria type II, without recourse to fasting. Analysis of blood spots obtained during metabolic stress occasionally reveals non-specific patterns, such as mild elevation of a number of acylcarnitine species. Under these circumstances, fasting may still be necessary to exclude 5-oxidation defects. Fasting failed to induce hypoglycaemia in 26 patients in whom it had been documented elsewhere, emphasising the importance of obtaining diagnostic specimens during the presenting episode. In 32 of the children who became hypoglycaemic during the fast, no diagnosis was established other than 'ketotic hypoglycaemia'. These children are likely to be a heterogeneous group, some representing the end of the normal spectrum, while others have a variety of mild metabolic or endocrine defects, such as poor glycogen stores,' impaired gluconeogenesis, or catecholamine deficiency.'
CONCLUSIONS
In conclusion, withdrawal of dietary energy and the measurement of hormone levels during subsequent hypoglycaemia is the key to diagnosis of hyperinsulinism. It should also detect adrenocortical insufficiency, though this must be confirmed by other tests. Single growth hormone measurements during fasting hypoglycaemia are seldom useful. Fasts remain valuable in identifying metabolic causes of hypoglycaemia but analysis of acylcarnitines by tandem mass spectrometry is a safer method for diagnosing some 5-oxidation defects. Diagnostic fasts need to be conducted on an experienced unit with frequent monitoring of blood glucose. Blood pH should also be monitored if acidosis accompanied hypoglycaemia during the presenting episode.
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